| Employment |
| Company: The Chinese University of Hong Kong |
| Recipient: You |
|
| Leadership |
| Company: AstraZeneca |
| Recipient: You |
| Company: Aurora Tele-Oncology Limited |
| Recipient: You |
| Company: Lunit |
| Recipient: You |
| Company: ACT Genomics-Sanomics Group |
| Recipient: You |
| Company: HUTCHMED |
| Recipient: You |
|
| Stock and Other Ownership Interests |
| Company: Aurora Tele-Oncology Limited |
| Recipient: You |
| Company: HUTCHMED |
| Recipient: You |
| Company: ACT Genomics-Sanomics Group |
| Recipient: You |
|
| Honoraria |
| Company: AstraZeneca |
| Recipient: You |
| Company: Alpha Biopharma |
| Recipient: You |
| Company: ACEA Pharmaceutical Research |
| Recipient: You |
| Company: Amgen |
| Recipient: You |
| Company: Amoy Diagnostics |
| Recipient: You |
| Company: BeiGene |
| Recipient: You |
| Company: Boehringer Ingelheim |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: Daiichi Sankyo/UCB Japan |
| Recipient: You |
| Company: Fishawack Facilitate |
| Recipient: You |
| Company: InMed Medical Communication |
| Recipient: You |
| Company: Lilly |
| Recipient: You |
| Company: Merck Sharp & Dohme |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Origimed |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Prime Oncology |
| Recipient: You |
| Company: Roche |
| Recipient: You |
| Company: Sanofi Aventis GmbH |
| Recipient: You |
| Company: Taiho Pharmaceutical |
| Recipient: You |
| Company: Takeda |
| Recipient: You |
| Company: Lucence Health Inc. |
| Recipient: You |
| Company: Medscape |
| Recipient: You |
| Company: P. Permanyer SL |
| Recipient: You |
| Company: PeerVoice |
| Recipient: You |
| Company: Physicans' Education Resource |
| Recipient: You |
| Company: Research to Practice |
| Recipient: You |
| Company: Shanghai BeBirds Translation & Consulting Co. |
| Recipient: You |
| Company: Liangyihui Network Technology Co., Ltd. |
| Recipient: You |
| Company: Abbvie |
| Recipient: You |
| Company: Berry Oncology |
| Recipient: You |
| Company: Blueprint Medicines |
| Recipient: You |
| Company: C4 Therapeutics |
| Recipient: You |
| Company: CStone Pharmaceuticals |
| Recipient: You |
| Company: Curio Science |
| Recipient: You |
| Company: D3 Bio Ltd. |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
| Company: Gritstone Oncology |
| Recipient: You |
| Company: Guardant Health |
| Recipient: You |
| Company: touchIME |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Abbvie |
| Recipient: You |
| Company: ACEA Pharmaceutical Research |
| Recipient: You |
| Company: Alpha Biopharma |
| Recipient: You |
| Company: Amgen |
| Recipient: You |
| Company: Amoy Diagnostics |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: BeiGene |
| Recipient: You |
| Company: Berry Oncology |
| Recipient: You |
| Company: Boehringer Ingelheim |
| Recipient: You |
| Company: Blueprint Medicines |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: CStone Pharmaceuticals |
| Recipient: You |
| Company: Curio Science |
| Recipient: You |
| Company: Daiichi Sankyo/UCB Japan |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: Fishawack Facilitate |
| Recipient: You |
| Company: Gritstone Oncology |
| Recipient: You |
| Company: Guardant Health |
| Recipient: You |
| Company: Hengrui Therapeutics |
| Recipient: You |
| Company: Ignyta |
| Recipient: You |
| Company: Incyte Corporation |
| Recipient: You |
| Company: Inivata |
| Recipient: You |
| Company: IQvia |
| Recipient: You |
| Company: Lilly |
| Recipient: You |
| Company: Loxo-Oncology |
| Recipient: You |
| Company: Lunit |
| Recipient: You |
| Company: Merck Serono |
| Recipient: You |
| Company: Merck Sharp & Dohme |
| Recipient: You |
| Company: Mirati Therapeutics |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Puma Biotechnology |
| Recipient: You |
| Company: Roche |
| Recipient: You |
| Company: SFJ Pharmaceuticals Group |
| Recipient: You |
| Company: Takeda |
| Recipient: You |
| Company: Vertex Pharmaceuticals |
| Recipient: You |
| Company: Yuhan |
| Recipient: You |
| Company: Qiming Development (HK) Ltd. |
| Recipient: You |
| Company: D3 Bio Limited |
| Recipient: You |
| Company: C4 Therapeutics |
| Recipient: You |
| Company: G1 Therapeutics |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
| Company: Janssen |
| Recipient: You |
| Company: geneDecode |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Boehringer Ingelheim |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: SFJ Pharmaceuticals Group |
| Recipient: Your Institution |
| Company: Roche |
| Recipient: Your Institution |
| Company: Merck Sharp & Dohme |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: Xcovery |
| Recipient: Your Institution |
| Company: G1 Therapeutics |
| Recipient: Your Institution |
| Company: Merck Serono |
| Recipient: Your Institution |
| Company: Takeda |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|